AskVantage

Syndex Bio

Syndex Bio is a startup headquartered in Santa Monica, United States, founded in 2022. It has raised at least $15.5m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.

Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .

2022Founded
StartupStage
Santa Monica, United StatesHeadquarters
BiotechnologyIndustry
$15.5m+Raised (SEC filings)
EarlyFunding stage
Biotechnology
See it on the interactive mapBook a Briefing

Funding

Syndex Bio has raised at least $15.5m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.

R&D ecosystem

Syndex Bio sits inside the Los Angeles and Southern California R&D ecosystem in the Global R&D Labs Directory.

Other startups in Santa Monica

Related

Questions and answers

What does Syndex Bio do?

Syndex Bio is classed in biotechnology in its filings with the US Securities and Exchange Commission.

How much has Syndex Bio raised?

At least $15.5m, according to its Form D filings with the US Securities and Exchange Commission.

Where is Syndex Bio based?

Syndex Bio is headquartered in Santa Monica, United States.

When was Syndex Bio founded?

Syndex Bio was founded in 2022.

Source record: SEC EDGAR (Form D filings).

© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.